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A key issue in otitis media is mucous cell metaplasia which is responsible for mucous hypersecretion and persistence of the disease.
However,littleisknownaboutthemolecularmechanismsofmucouscellmetaplasiainotitismedia.Numerousstudiesofintestinal
epithelialhomeostasishaveshownthatAtonalhomolog1(Atoh1),abasichelix-loop-helix(bHLH)transcriptionfactor,isessential
fortheintestinalgobletcelldiﬀerentiation.Ontheotherhand,SAM-pointeddomain-containingEtstranscriptionfactor(SPDEF),
a member of the “Ets” transcription factor family, has been reported to trigger the mucous cell metaplasia of pulmonary infectious
diseases or athsma. Recent studies have demonstrated the relation of these factors, that is, Spdef functions downstream of Atoh1.
We could take the adventages of these ﬁndings for the study of otitis media because both middle ear and pulmonary epithelia
belong to the same respiratory tract. Atoh1 and SPDEF could be the therapeutic targets for otitis media associated with mucous
cell metaplasia which is frequently considered “intractable” in the clinical settings.
1. MucousCell MetaplasiainIntractable
OtitisMedia
One of the most characteristic features of intractable otitis
media is mucous hypersecretion. Chronic otitis media,
caused by a prolonged bacterial infection, is characterized by
eardischargethatis richin mucus.Otitis media withmucoid
eﬀusion, common in young child otitis media patients and
caused by a combination of bacterial infection and dysfunc-
tion of the Eustachian tube [1], is characterized by thick ﬂuid
accumulation in the middle ear cavity. Eosinophilic otitis
media, which is a newly recognized intractable otitis media
with bronchial asthma, is characterised by the presence of a
highly viscous yellow eﬀusion containing eosinophils [2].
The pathological basis of the mucous hypersecretion is
mucous cell metaplasia, abnormal transformation of the
normal respiratory tract mucosa into a thickened mucosa
with a high density of the goblet cell population in response
to microorganic infections or asthma. In a murine model of
asthma, there was a dramatic increase in goblet cell number
accompanied by a 75% decrease in Clara cells and a 25%
decrease in ciliated cells after allergen challenge with a total
number of epithelial cells being constant [3]. The increase
of goblet cells and decrease of ciliated cells are also reported
in the rat model of otitis media with eﬀusion induced by
the endotoxin plus Eustachian tube obstruction [4]. These
ﬁndings suggest that the ciliated cells convert to goblet cells
under the pathological conditions via a biologic process
calledcell transdiﬀerentiation. It has been demonstrated that
variousmaterialssuchasbacteria[1],lipopolysaccharide[5],
tumor necrosis factor-alpha (TNF-α)[ 6], and interleukin-
10 (IL-10) [7] are involved in mucous cell metaplasia of the
middle ear mucosa.
Mucins serve critical functions in the host defense
against microorganisms. They are the principal structural
components of the mucociliary transport system and the2 International Journal of Otolaryngology
pathogens entrapped in a mucin gel layer are eliminated by
constant beatings of the cilia on the mucosal surface. Under
normal conditions, few mucous cells exist in the middle ear
mucosa and they are mainly distributed in the oriﬁce of the
Eustachian tube, promontory area, and inferior tympanium.
However, under pathological conditions inducing mucous
cell metaplasia, an increased goblet cell population in the
mucosa produces excessive mucins, while the loss of ciliated
cells in the mucosa results in the dysfunction of the mu-
cociliary transport system, leading to subsequent problems
such as ﬂuid accumulation and repeated infections. It is
necessary to understand the disease mechanism of mucous
cell metaplasia in order to cure this intractable illness.
2. The Role of Atoh1 in
Mucous Cell Differentiation
Atonal homologue 1 (Atoh1), also called the mouse atonal
homolog 1 (Math1) gene in mice and the human atonal
homolog 1 (Hath1) gene in humans, is one of the candidate
genes which play a crucial role in the mucous cell metaplasia.
Atoh1 is a basic helix-loop-helix (bHLH) transcription factor
that is essential for the intestinal goblet cell diﬀerentiation.
It has been shown that goblet cells are completely abrogated
in the intestine of Math1-null mouse [8]. Math1-null
embryos die at birth due to respiratory failure and lack
of many speciﬁc cell lineages, including not only intestinal
secretory cells but also cerebellar granule neurons, spinal
cord interneurons, and inner ear hair cells [9].
The role of Atho1 in goblet cell diﬀerentiation has been
well studied in the intestine. The epithelium of the small
intestine is composed of four diﬀerent cell types: absorptive
enterocytes and three secretory lineages consisting of mucus-
secreting goblet cells, hormone-secreting enteroendocrine
cells, and antimicrobial peptide-secreting Paneth cells. The
intestinal epithelium is a highly dynamic tissue and is
replaced by newly diﬀerentiated cells from multipotent stem
cells residing near the base of the Crypts in every 2–7
day [9]. The diﬀerentiation for an absorptive or secretory
cell linage is controlled by the Notch signaling system in
a manner of lateral inhibition (Figure 1). Notch is a cell
surface receptor that binds to Notch ligands, Dll (Delta-
like), and Jagged families. Notch ligand, secreted from a
progenitor cell which has a fate to become a goblet cell,
binds to the Notch receptor on the other neighboring
progenitor cell. This Notch receptor activation decides the
fate of the neighboring cell because the Notch target gene
Hairy/enhancer-of-split 1 (Hes1) inhibits the Atoh1. In this
way, the neighboring progenitor becomes an absorptive
cell. Akiyama et al. [10] has shown Atoh1 is one of the
downstream genes of Notch ligands and Atoh1 is involved in
the mechanisms of cellular diﬀerentiation from progenitor
cells to goblet cells. They showed that Dll1 and Dll4 were
selectively expressed in goblet cells within the human colonic
epithelium and knockdown of Dll1 abrogated the Hath1
and MUC2 gene expression under activation of the goblet
cell genes by a Notch signal inhibitor, suggesting the Notch
ligand triggers the goblet cell diﬀerentiation through Atoh1
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Figure 1: A schematic representation of lateral inhibition by a
Notch ligand. A Notch ligand secreting cell releases a Notch ligand
that binds to the Notch receptor of a neighboring cell. The action
inhibits the activity of Atoh1 through Notch target gene Hes1 in the
cell, leading to the formation of an absorptive cell. While a Notch
ligand secreting cell has a high activity of Atoh1, leading to the
diﬀerentiation of a goblet cell.
activation. They have also reported forced expression of the
Notch1 intracellular domain, an intracellular component
of the Notch receptor, signiﬁcantly suppressed Dll1, Dll4,
MUC2,a n dHath1 gene expression, suggesting that notch
receptoractivationpreventsAtoh1 from triggering goblet cell
diﬀerentiation by blocking the Notch ligand expression.
MUC2 is speciﬁcally expressed in the goblet cells of
the intestine and thought as a goblet cell marker [11].
Park et al. found that Hath1 directly activated transcription
of MUC2 gene in the human intestinal epithelial cells
[12]. In the human gastric cancer cells, overexpression of
Math1 strongly enhanced both the MUC6 and MUC5AC
mRNA transcript levels and knockdown of the Hath1
gene signiﬁcantly decreased the expression of both mucin
genes [13].
T h er o l eo fAtoh1 in mucous cell development is well
studied.However,theroleofAtoh1 inmucouscellmetaplasia
under diseased conditions is underinvestigated. An infection
of whipworm (Trichuris muris) in the mouse intestine is
reported to induce mucous cell metaplasia where Math1 is
signiﬁcantly upregulated in the mRNA level [14].
3.TheRoleofSPDEFinMucousCellMetaplasia
SAM Pointed Domain ETS Factor (SPDEF, also termed
PDEF or PSE) is another candidate controlling mucous cell
metaplasia.Itisamemberofthe“Ets”familywhichregulates
anumberofbiologicalprocesses,includingcellproliferation,
diﬀerentiation, and invasion. SPDEF was ﬁrst described as
a factor interacting with the androgen receptor to enhance
expression of the prostate-speciﬁc antigen (PSA) promoter
in vitro [15].
The role of SPDEF in mucous cell metaplasia is well
attended in the study of lung diseases. SPDEF was markedly
increased at sites of mucous cell metaplasia in bronchial
tissuesfrompatientswithCysticﬁbrosisorcigarettesmoking
[16]. In a murine model of asthma, the expression ofInternational Journal of Otolaryngology 3
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Figure 2: The diﬀerentiation path of a goblet cell starting from a
progenitor and the genes involved in this process. An intestine stem
cell becomes an absorptive cell in the absence of the Atoh1 protein
but activation of Hes1 or becomes a secretory progenitor cell under
the inﬂuence of Atoh1 protein with the potential to become either
enteroendocrine cells under the direction of neurogenin 3 (Ngn3)
or goblet cells under the direction of GFI1 and SPDEF.
Math1
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Figure 3: Math1 transfection increases the mucous cells in the
middle ear mucosa of mice. Full-length Math1 cDNA was cloned
into a protein-expressing vector (C2, pEGFP, Clontech). To study
the role of Math1 in the middle ear mucosa, bilateral bullae of
5 mice were transfected with 10μLo fMath1 and empty vectors,
respectively, at 1.4μg/mL in Opti-MEM containing Lipofectin
at 6μg/mL via the tympanic membrane approach. Transfected
animals were sacriﬁed 7 days after Math1 transfection for harvest
of the bullae. Math1 transfection had more AB-PAS positive cells
in the mouse middle ear mucosa (upper) than empty vector (C2)
transfection (lower). Bar = 10μm.
SPDEF was also increased at sites of mucous cell metaplasia
caused by IL-13 and dust mite allergen [17]. Chen et al.
[16] have shown the Clara cell turns to goblet cell in
the lung within 3 days after expression of SPDEF using
a transgenic mouse model where the expression of Spdef
gene under the Clara cell-speciﬁc promoter is controlled
by doxycyline concentration (Scgb1a1-rtTA/TRE2-Spdef).
This process is rapidly reversible and associated with the
restoration of the Clara cells after stopping of the SPDEF
expression. They have also reported some genes under the
control of SPDEF. An mRNA microarray analysis study
showed the expression of SPDEF inﬂuenced more than 300
genes including mucin 16 (MUC16), anterior gradient 2
(AGR2), glucosaminyl (N-acetyl) transferase 3, mucin type
(Gcnt3), and chloride channel calcium activated 1 (Clca1).
The involvement of these genes was conﬁrmed by others.
MUC5AC, AGR2, and Clca1 induced by IL-13 treatment
were reduced in Spdef knockout human airway epithelial
cells [18]. In colon cancer cells to activate the goblet cell
genes by Notch signal inhibitors, knockdown of Spdef also
repressedtheexpressionofMUC2andAGR2 [19].Mucinisa
large-molecular-weight glycoprotein and mucin production
requires several steps including transcription of a MUC
gene, holding, multimerization, and glycosylation. MUC
genes code core mucin protein. AGR2 is a member of
protein disulﬁde isomerase (PDI) family which is critical
for eﬃcient formation of correctly arranged disulﬁde bonds
in the endoplasmic reticulum (ER) [20]. Gcnt3 is involved
in the synthesis of a core structure in the mucin glycan
chain. Clca1, whose mouse homolog is called as Gob5,i s
believed to have a role in secreting chloride anions into the
lumen and contributing to the salt and water composition
of secreted mucins [21]. All these genes contribute the
production of mature mucins, which is conducted in the
well-diﬀerentiated goblet cells. Inversely, blockage of SPDEF
results in a failure of goblet cell maturation. The intestine
of Spdef knockout mice revealed a severe loss of mature
goblet cells and Paneth cells accompanied by accumulation
of immature secretory progenitors. The typical aberrant
goblet cells in Spdef knockout mice exhibit a clear brush
border similar to adjacent enterocytes and carry poorly
deﬁned vacuoles in their cytoplasm. These immature goblet
cells probably initiate the diﬀerentiation of goblet cells
because they expressed trefoil factor 3 (TFF3), which is
one of the goblet cell markers and thought to help in the
oligomerization of mucin polysaccharides, although they did
not have Alcian Blue Periodic Acid-Schiﬀ (AB-PAS)-positive
granules [22]. These data suggests SPDEF is a factor to serve
for the terminal diﬀerentiation of goblet cells rather than to
initiate or trigger the diﬀerentiation of goblet cells. SPDEF
is thought to be a key transcription factor to start a series
of sequential gene activations for the terminal diﬀerentiation
and maturation of goblet cells.
4.SPDEF Functions as a Downstream Molecule
of Atoh1
AccumulatedpiecesofevidenceindicatethatSpdef functions
downstream of Atoh1, and this is mediated by another
transcription factor, growth-factor-independent 1 (GFI1),
which is normally expressed in the both Paneth and goblet
cells (Figure 2). SPDEF was absent from intestine of the
Math1-nullmouse and wasalsoquantitatively reduced in the
GFI1-null mouse [19]. GFI1 is thought to be downstream of
Atoh1 because the Math1 expression was still observed in the
GFI1-null mouse [9]. Atoh1-null crypts lack all the intestinal4 International Journal of Otolaryngology
MUC2 TFF3 Math1
Control
TNFα +R A
Figure 4: Mouse middle ear epithelial cells were incubated with 20ng/mL of TNFα and 10−9 Mo fR Af o rt w ow e e k so n8 - w e l lc h a m b e r
slides (media and factors were supplied every two days). Immunohistochemistry showed that these factors increased the expression of goblet
cell markers, MUC2 and TFF3, suggesting that this could be a model of mucous cell metaplasia in infectious otitis media. Math1 was located
only in the cytoplasm in the control culture, however, the administration of TNFα + RA made Math1 translocate into nuclei. This Math1
activation (translocation to nuclei) probably triggers the expression of MUC2 and TFF3.
secretory cells. On the other hand, GFI1-null crypts lack
Paneth cells, have few goblet and supernumerary enteroen-
docrine cells. These ﬁndings indicate the selection between
secretorycells(gobletcells,Panethcells,andenteroendocrine
cells) and absorptive cell is dependent on Atoh1, and the
selection between goblet/Paneth and enteroendocrine cells is
dependent on GFI1 [9].
5. The Role of Atoh1 inOtitisMedia
There is no report to discuss the involvement of Atoh1,
GFI1,o rSpdef in otitis media. However, the similarity of the
middle ear epithelium to the pulmonary epithelium, Atoh1,
the upstream gene of Spdef which is involved in several
pulmonary diseases, may also have a role in the mucous
cell metaplasia of otitis media. To test this hypothesis, we
performed the transfection of Math1 in the mouse middle
ear. It wasfound that mucous cellnumbers were signiﬁcantly
increased in Math1 transfected middle ears compared with
empty vector transfection (Figure 3). We also evaluated the
eﬀects of administration of TNFα,w h i c hi sac o m m o n
proinﬂammatory cytokine induced by bacterial or virus
infection, and retinoic acid (RA) on mouse middle ear
epithelial cells [23]. The administration of these factors for
two weeks synergistically promoted the expression of MUC2
and TFF3 with an activation of Math1 in vitro (Figure 4).
These data suggest that Atoh1 activated by proinﬂammatory
cytokines triggers the mucous cell metaplasia in the middle
ear epithelium as well.
6. Conclusions
Over the past decade there have been signiﬁcant advances
in the studies of intestinal epithelial homeostasis and pul-
monary mucous cell metaplasia. The former studies found
Atoh1 as a factor to trigger the diﬀerentiation of goblet
cells, and the latter studies found SPDEF as a factor to be
responsible for mucous cell metaplasia, respectively. Now
we can take advantages of these molecular understanding
about mucous cells for the therapy of otitis media. Mucous
cell metaplasia is a very primitive response to pathogens.
Originally, this response is to protect the mucociliary
system by secreting more mucins and their chaperones.
These secreted substances are supposed to lubricate the
lumen of the respiratory tract and discharge hazardous
materials. However, mucous cell metaplasia also disturbs
the well-organized mucociliary transport system at the
expense of ciliated cells. Excessive mucus severely impairs
the function of the mucociliary transport system and leads
to subsequent infections. To make matter worse, bacterial
cell wall components, or inﬂammatory cytokines trapped
in accumulated mucus can be a driving force again for
mucous cell metaplasia and thus form a vicious cycle. This
vicious circle could explain why mucous cell metaplasia
prolongs infectious diseases on a long-term basis. The
eﬀectiveblockageoftheAtoh1,SPDEF,orGFI1expressionin
the early phase of disease may be a new strategy for treating
intractable otitis media. It could break the vicious circle of
mucous cell metaplasia and lessen the burden of otitis media
patients with mucoid eﬀusion.
References
[1] Y. Tsuboi, Y. Kim, G. S. Giebink et al., “Induction of mucous
cell metaplasia in the middle ear of rats using a three-step
method: an improved model for otitis media with mucoid
eﬀusion,” Acta Oto-Laryngologica, vol. 122, no.2, pp. 153–160,
2002.
[2] Y. Iino, “Role of IgE in eosinophilic otitis media,” Allergology
International, vol. 59, no. 3, pp. 233–238, 2010.
[3] J. R. Reader, J. S. Tepper, E. S. Schelegle et al., “Pathogenesis of
mucous cell metaplasia in a murine asthma model,” American
Journal of Pathology, vol. 162, no. 6, pp. 2069–2078, 2003.International Journal of Otolaryngology 5
[4] M. J. Nell and J. J. Grote, “Structural changes in the rat
middle ear mucosa due to endotoxin and eustachian tube
obstruction,” European Archives of Oto-Rhino-Laryngology,
vol. 256, no. 4, pp. 167–172, 1999.
[5] S.E.H unt e r ,A.K.S ingla,J .P razma,B .S.J ew ett,S.H.Randell,
and H. C. Pillsbury, “Mucin production in the middle ear in
response to lipopolysaccharides,” Otolaryngology—Head and
Neck Surgery, vol. 120, no. 6, pp. 884–888, 1999.
[6] H. Kawano, A. Haruta, Y. Tsuboi et al., “Induction of
mucous cell metaplasia by tumor necrosis factor alpha in rat
middle ear: the pathological basis for mucin hyperproduction
in mucoid otitis media,” Annals of Otology, Rhinology and
Laryngology, vol. 111, no. 5 I, pp. 415–422, 2002.
[ 7 ]K .T s u c h i y a ,M .K o m o r i ,Q .Y .Z h e n g ,P .F e r r i e r i ,a n dJ .
Lin, “Interleukin-10 is an essential modulator of mucoid
metaplasia in a mouse otitis media model,” Annals of Otology,
Rhinology and Laryngology, vol. 117, no. 8, pp. 630–636, 2008.
[8] Q. Yang, N. A. Bermingham, M. J. Finegold, and H. Y. Zoghbi,
“Requirement ofMath1forsecretorycell lineage commitment
in the mouse intestine,” Science, vol. 294, no. 5549, pp. 2155–
2158, 2001.
[ 9 ]N .F .S h r o y e r ,D .W a l l i s ,K .J .T .V e n k e n ,H .J .B e l l e n ,
and H. Y. Zoghbi, “Gﬁ1 functions downstream of Math1
to control intestinal secretory cell subtype allocation and
diﬀerentiation,” Genes and Development, vol. 19, no. 20, pp.
2412–2417, 2005.
[10] J. Akiyama, R. Okamoto, M. Iwasaki et al., “Delta-like 1
expression promotes goblet cell diﬀerentiation in Notch-
inactivated human colonic epithelial cells,” Biochemical and
Biophysical Research Communications, vol. 393, no. 4, pp. 662–
667, 2010.
[ 1 1 ]C .M .W i n t e r f o r d ,M .D .W a l s h ,B .A .L e g g e t t ,a n dJ .R .
Jass, “Ultrastructural localization of epithelial mucin core
proteins in colorectal tissues,” Journal of Histochemistry and
Cytochemistry, vol. 47, no. 8, pp. 1063–1074, 1999.
[12] E. T. Park, H. K. Oh, J. R. Gum et al., “HATH1 expression
in mucinous cancers of the colorectum and related lesions,”
Clinical Cancer Research, vol. 12, no. 18, pp. 5403–5410, 2006.
[13] A. Sekine, Y. Akiyama, K. Yanagihara, and Y. Yuasa, “Hath1
up-regulates gastric mucin gene expression in gastric cells,”
Biochemical and Biophysical Research Communications, vol.
344, no. 4, pp. 1166–1171, 2006.
[14] S. Z. Hasnain, D. J. Thornton, and R. K. Grencis, “Changes
in the mucosal barrier during acute and chronic Trichuris
muris infection,” Parasite Immunology, vol. 33, no. 1, pp. 45–
55, 2011.
[15] P. Oettgen, E. Finger, Z. Sun et al., “PDEF, a novel prostate
epithelium-speciﬁc Ets transcription factor, interacts with the
androgen receptor and activates prostate-speciﬁc antigen gene
expression,” Journal of Biological Chemistry, vol. 275, no. 2, pp.
1216–1225, 2000.
[ 1 6 ]G .C h e n ,T .R .K o r f h a g e n ,Y .X ue ta l . ,“ S P D E Fi sr e q u i r e df o r
mouse pulmonary goblet cell diﬀerentiation and regulates a
network of genes associated with mucus production,” Journal
of Clinical Investigation, vol. 119, no. 10, pp. 2914–2924, 2009.
[17] K. S. Park, T. R. Korfhagen, M. D. Bruno et al., “SPDEF
regulates goblet cell hyperplasia in the airway epithelium,”
Journal of Clinical Investigation, vol. 117, no. 4, pp. 978–988,
2007.
[18] H. Yu, Q. Li, V. P. Kolosov, J. M. Perelman, and X. Zhou,
“Interleukin-13 induces mucin 5AC production involving
STAT6/SPDEF in human airway epithelial cells,” Cell Commu-
nication and Adhesion, vol. 17, no. 4-6, pp. 83–92, 2011.
[19] T. K. Noah, A. Kazanjian, J. Whitsett, and N. F. Shroyer,
“SAM pointed domain ETS factor (SPDEF) regulates terminal
diﬀerentiation and maturation of intestinal goblet cells,”
Experimental Cell Research, vol. 316, no. 3, pp. 452–465, 2010.
[20] S.W.Park,G.Zhen,C.Verhaegheetal.,“Theproteindisulﬁde
isomerase AGR2 is essential for production of intestinal
mucus,” Proceedings of the National Academy of Sciences of the
UnitedStatesofAmerica,vol.106,no.17,pp.6950–6955,2009.
[21] P. Thai, Y. Chen, G. Dolganov, and R. Wu, “Diﬀerential regu-
lationofMUC5AC/Muc5acandhCLCA-1/mGob5expression
inairwayepithelium,”AmericanJournalofRespiratoryCelland
Molecular Biology, vol. 33, no. 6, pp. 523–530, 2005.
[22] A. Gregorieﬀ, D. E. Stange, P. Kujala et al., “The Ets-domain
transcription factor Spdef promotes maturation of goblet and
panethcellsintheintestinalepithelium,”Gastroenterology,vol.
137, no. 4, pp. 1333–e3, 2009.
[23] K.Tsuchiya,Y.Kim,F.G.Ondrey,andJ.Lin,“Characterization
of a temperature-sensitive mouse middle ear epithelial cell
line,” Acta Oto-Laryngologica, vol. 125, no. 8, pp. 823–829,
2005.